Clinical trial

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected…

NCT00411957 · The HIV Netherlands Australia Thailand Research Collaboration, Other · Completed

Key facts

NCT number NCT00411957
Title Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients
Official title The Pharmacokinetics of Atazanavir / Ritonavir 200/100 OD Versus 300/100 mg OD in Combination With 2 NRTIs in HIV Pre-treated Patients
Lead sponsor The HIV Netherlands Australia Thailand Research Collaboration, Other
Collaborators Bristol-Myers Squibb Industry
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Atazanavir
Enrollment 22
Start date Jan 1, 2007
Primary completion Jan 1, 2008
Completion Jan 1, 2008
First posted Dec 15, 2006
Last update posted Jul 17, 2020
Countries Thailand

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies